# GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

> **NCT00305669** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 24 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** sargramostim
- **OTHER:** immunohistochemistry staining method
- **OTHER:** immunological diagnostic method
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00305669
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2011-01
- **Final completion:** 2014-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305669, "GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00305669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*